ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MDST Medicsight

0.45
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medicsight LSE:MDST London Ordinary Share GB00B1YD4B09 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.45 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Medicsight Share Discussion Threads

Showing 26 to 50 of 550 messages
Chat Pages: Latest  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
23/6/2007
09:36
This from the parent company, MGT, 22nd June 2007.

"Following the completion of Medicsight's placing on June 21, 2007, the Company's shareholding in Medicsight is 85,000,000 shares representing 54.7 per cent of the issued share capital."

Takeover proof, without MGT's approval/agreement. Interesting times ahead. Fryern, thanks for the data.

damanko
23/6/2007
09:05
This is what it's all about:-

The London-based venture's technology reduces human error in the computer-aided detection (CAD) of potential anomalies in lung and colon CT scans. This, said MedicSight's chief executive David Sumner, can increase the accuracy of a bog-standard radiographer's 40 per cent success at spotting problems up to '90 per cent-plus, above the competency of an expert'.

Sumner stated that the technology speeds up the time it takes to analyse results 'by roughly half' and means hospitals can also employ 'cheaper staff members and still get better results'. Such techniques have existed in the US in the areas of breast and lung examination but, believes Sumner, 'the efficiency and accuracy of existing CAD is more hit and miss'.

fryern
23/6/2007
08:57
Here are the sums:

Sharecast:-

Medicsight got off to a strong start Thursday and extended gains at the end of the week, soaring to 132p from a placing price of 110p, valuing the firm at over £200m.

MGT has 40m shares

Holds:-

90m Medicsight plc shares = $237.60m (90 x £1.32 x 2 dollars to a £1)
45m Medicsight Exchange shares = $99m
Cash $25m

Add it up and divide by 40m

=$8.81

Price on AMEX $5.50ish to buy

(Note Medicsight Exchange share value comes from a circular).

The short term target price for MGT is $20.
Target price for MDST is £4 short term................

So

MGT

90m Medicsight plc shares = $720m (90 x £4.00 x 2 dollars to a £1)
45m Medicsight Exchange shares = $99m
Cash $25m

= $21.1

fryern
22/6/2007
22:27
MGT CAPITAL INVTS INC (MGT)
5.40 +0.55 (+11.34%)

This is the cheap way in still

MGT own 55% of MSDT........should be $7+

If you want the sums I have them from the company

fryern
22/6/2007
17:48
Better still skin all3

Back to basics

This proven product is the automatic detection of early cancers.

If you detect cancer early enough the survival rates are much much better.

fryern
22/6/2007
17:45
You have to understand that many 'Angel' shareholders have been locked in for over 6 years.

They are bound to let a few go. Once that happens/drys up, the only way is up - there will be very little stock.

Clever way in is via MGT that owns 55% - used to be 100%. Quoted on AMEX.

Target price is in excess of $20 within 3 years now $5. Current price of MDST values MGT in excess of $7.

What will drive the price of both up is the announcement of who is the scanning comapny they are going into bed with.

I see only 3

Siemens, Toshiba or GE.

I know they have been talking to all 3.

fryern
22/6/2007
15:17
...absolutely!! picked up a few at 125p and no much around by the looks of things.
markralph
22/6/2007
13:48
auction again, would appear no stock to sell, worth seizing the opportunity here.
bigbobjoylove
22/6/2007
13:28
If this follows the pattern of its "sister" Accsys Technologies, it may not pull back very much at all. Niche type stuff again, market clearly likes it, IPO'd on a day the LSE was largely a sea of red. Await news now on a license deal with one of the global scanning hardware manufacturers.

Then MDST may well take off.

As Fryern would say........."You heard it first here".

damanko
22/6/2007
12:56
why all the auctions when no trading hardly?
bigbobjoylove
22/6/2007
12:55
BBJ. Well done.I was far to slow but keeping an eye on it.I shall jump on if it pulls back a tad.
sllab101
22/6/2007
12:52
top man cheers. Money@m showing a blank book. I'm in from 125.5 with just 5000.
bigbobjoylove
22/6/2007
12:50
BBJ - L2 OK ON ADVFN.

Not much on it sell mm 5k 138 and 2.5k 140
buy 10k 135 then mm again2.5 135 and 5k 135.

sllab101
22/6/2007
12:27
can anyone see level2? can't see it on money@m.
bigbobjoylove
22/6/2007
10:48
Anyone have any financials? Looked on the website but they're not detailed and the prospectus isn't listed.
wjccghcc
21/6/2007
20:36
To MGT shareholders .......


June 21, 2007



Dear Stockholder

You may well have seen some press over the last two weeks relating to the Initial Public Offering ("IPO") of our subsidiary, Medicsight PLC on the London Stock Exchange's Alternative Investment Market ("AIM").

The reasons for the Medicsight PLC floatation were:

1. to raise a net $60M in Medicsight PLC - which means that Medicsight PLC will require no further funding from MGT;

2. to use part of the IPO proceeds to repay the final piece of debt (approximately $11.5M) back to MGT;

3. to leave sufficient funds in Medicsight PLC for working capital and business development.

I am delighted to announce that the IPO was completed on schedule and Medicsight PLC's shares were listed on the AIM exchange on June 21 under the ticker symbol "MDST".

Immediately prior to the IPO, MGT sold down 11.7M Medicsight PLC shares in a private placement at £1.10, yielding net cash proceeds of $24M to MGT. This left MGT with 85M Medicsight PLC shares which will have a valuation of £1.10 to £3.50 on a 3 year target range.

These actions had the benefit of:

a. releasing significant cash for future MGT investments;

b. crystallising a market value for the remaining 85M Medicsight shares that we hold;

c. reducing the MGT holding in Medicsight to a 55% controlling stake.

Post these transactions, MGT could have a current and potential Net Asset Value as follows:

$7 to over $20 it won't cut and paste!!



This does not include the full potential upside value in our cash investments or to our investment in Medicexchange. I am pleased to report that the investment in Medicexchange is beginning to reach fruition and we are generating substantial well targeted traffic to the website together with a wide variety of products for sale. Our planned sales will come both from on-line and off-line transactions as well as advertising revenues. We will be testing a variety of pricing strategies over the next few months, all of which I hope will have a positive impact on our value.

We have refreshed our websites and you may wish to review the press cuttings and other dialogue relating to these events. www.mgtci.com www.medicsight.com www.medicexchange.com

Thank you for your continued support.

Kind regards
Yours sincerely



TIM PATERSON-BROWN
Chairman and Chief Executive Officer

fryern
21/6/2007
20:33
What Medicsight have is a World WINNER

Soon you won't need a Radiolgist present at your scan.

It will be automatic and only those that have a problem will be passed for a second opinion.

This is early cancer and other diseases detection 'population scanning' at it's very best.

FRom David Sumner..........

Boasting technologies that help hospitals speed up their cancer screening processes, MedicSight is looking to come to AIM with a £30 million June flotation.

The London-based venture's technology reduces human error in the computer-aided detection (CAD) of potential anomalies in lung and colon CT scans. This, said MedicSight's chief executive David Sumner, can increase the accuracy of a bog-standard radiographer's 40 per cent success at spotting problems up to '90 per cent-plus, above the competency of an expert'.

fryern
21/6/2007
20:27
June 20 2007

Dear Shareholder,

You may have seen the recent coverage in the UK business press announcing Medicsight PLC's intention to list on AIM on the London stock exchange.

It gives both of us great pleasure to announce that the much anticipated flotation on AIM will take place tomorrow on June 21 2007. The details of the listing are as follows:

Exchange: AIM London Stock Exchange
Ticker: MDST
Placing price: £1.10
Placing shares issued: 29,090,909
Ordinary shares in issue on admission: 155,524,904
Gross proceeds of the placing: £32,000,000
Net proceeds of the placing: £30,400,000
Market Capitalisation on placing: £171,077,395

This event represents yet another key milestone in the company's history. The proceeds of this transaction will enable us to continue to realise the vision set out at the company's inception, the funds of which will be used:

1. to further bolster the company's product pipeline via organic growth and acquisition
2. to enable long term clinical and commercial commitments to our existing partners

At this point, we would like to extend our thanks to all new and existing shareholders for their ongoing and future support and to the Medicsight team, who through their commitment and drive have made it possible for this to happen. Together, we look forward to watching this exciting story unfold.


Kind regards




Tim Paterson-Brown David Sumner
Chairman Chief Executive Ofiicer

fryern
21/6/2007
20:26
Wiganer

I had my complementry heart scan at Ravenscourt.

Now on the pills - thanks Stefan.

Cheap way into this is MGT quoted on AMEX who hold 55%. $4.8 should be $7.

Very interesting to see who put up the £32m

MDST placed at 110p closed at 120p.

Now a shed load of Angels have been locked into this for at least 6 years and will want some of their stakes out. Once that has gone the only way is UP>

fryern
21/6/2007
13:44
They opened a "flagship" place at the top of Victoria Street, very plush, great looking receptionists. I visited it about 4/5 years ago. I believe they closed it as overheads at that stage of the company's development were too onerous. Concentrating now on large deals with the scanning machine manufacturers, of which there are not many - worldwide. Somehow I think that announcements are not far off.

To take Accsys as an example, a fairly quiet IPO, followed by consistent positive press comment, and a very decent looking upward share price graph, only been quoted for about 22 months.

Expecting regulatory approval for the software in the States & Japan in 2008.

damanko
21/6/2007
11:51
lifesyne closed few years back so they could concentrate on core business rather than end user kit
moverman
21/6/2007
11:41
I did, couldn't find the info, hence why I asked here.
wiganer
21/6/2007
11:40
you might try looking at the website full of info
moverman
21/6/2007
11:27
Wasn't Medicsight's London (Lifesyne Clinic) based at Ravenscourt Park, which has now closed as an NHS Hospital? What UK operations do they now have?
wiganer
21/6/2007
11:25
all working click trades icon at top of page!!
moverman
Chat Pages: Latest  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock